ArticleBritish journal of pharmacology2017

Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.

C Marin-Bañasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.